首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity
【24h】

Amino acid and peptide prodrugs of diphenylpropanones positive allosteric modulators of α7 nicotinic receptors with analgesic activity

机译:二苯基丙酮的氨基酸和肽前药具有α7烟碱受体的α7烟碱受体的阳性变构调节剂

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract α7 Nicotinic acetylcholine receptors (nAChRs) are ion channels implicated in a number of CNS pathological processes, including pain and psychiatric, cognitive and inflammatory diseases. Comparing with orthosteric agonism, positive allosteric modulation of these channels constitutes an interesting approach to achieve selectivity versus other nicotinic receptors. We have recently described new chalcones and 1,3-diphenylpropanones as positive allosteric modulators (PAMs) of α7 nAChRs, which proved to have good analgesic activities but poor pharmacokinetic properties. Here we report the preparation of amino acid and peptide derivatives as prodrugs of these modulators with the aim of improving their in?vivo biological activity. While the valine derivative showed very short half life in aqueous solutions to be considered a prodrug, Val-Val and Val-Pro-Val are suitable precursors of the parent 1,3-diphenylpropanones, via chemical and enzymatic transformation, respectively. Compounds 19 (Val-Val) and 21 (Val-Pro-Val), prodrugs of the 2′,5′,4-trihydroxy-1,3-diphenylpropan-1-one 3 , showed significant antinociceptive activity in in?vivo assays. The best compound, 21 , displayed a better profile in the analgesia test than its parent compound 3 , exhibiting about the same potency but long-lasting effects. Graphical abstract Display Omitted Highlights ? Amino acid/peptide prodrugs of 1,3-diphenylpropanone α7 nAChRPAMs are described. ? Val-Val and Val-Pro-Val are suitable promoieties. ? Val-Pro-Val derivative exhibited long-lasting analgesic effect than the parent drug.
机译:摘要α7烟碱乙酰胆碱受体(NACHRS)是在许多CNS病理过程中涉及的离子通道,包括疼痛和精神病学,认知和炎症性疾病。与矫形激动主义相比,这些通道的积极构建调节构成了实现选择性与其他烟碱受体的有趣方法。我们最近描述了新的Chalcones和1,3-二苯基丙酮作为α7NACHRS的阳性变构调节剂(PAMS),其证明具有良好的镇痛活动,但药代动力学性质差。在这里,我们将氨基酸和肽衍生物的制备作为这些调节剂的前药,目的是改善其体内生物活性。虽然缬氨酸衍生物在水溶液中显示出非常短的半衰期,以被认为是前药,Val-val和Val-Pro-Val分别是亲本1,3-二苯基丙酮酮的合适前体,通过化学和酶促转化。化合物19(Val-Val)和21(Val-Pro-Val),2',5',4-三羟基-1,3-二苯基丙烷-1-1-one 3的前药在α体内测定中显示出显着的抗伤害活性。最好的化合物21,在镇痛试验中显示出比其母体化合物3更好的概况,表现出相同的效力但长期效果。图形抽象显示省略了亮点?描述了1,3-二苯基丙酮α7nachrPAM的氨基酸/肽前药。还是Val-Val和Val-Pro-Val是合适的凸起。还是Val-Pro-Val衍生物表现出比母体药物的持久镇痛作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号